Skip Navigation
Menu
Letters |15 November 2016

Reversal of Alopecia Universalis by Tofacitinib: A Case Report

Morton Scheinberg, MD, PhD; Sineida Berbert Ferreira, MD

Article, Author, and Disclosure Information
Author, Article, and Disclosure Information
×
FULL TEXT
Background: Alopecia universalis involves complete hair loss in all parts of the body (1). It is considered to be an advanced form of alopecia areata, which involves hair loss on some parts of the body, often in sharply demarcated areas. The cause of alopecia universalis is uncertain, but many investigators believe it to be an autoimmune disease with the patient's immune system directed against the hair follicles. In support of this hypothesis, clinical and experimental studies have shown infiltration by T lymphocytes into the immunologically privileged zone around the hair follicle with changes in cytokine and chemokine profiles...
FULL TEXT
PDF
Not Available
Citations
Citation

Scheinberg M, Ferreira SB. Reversal of Alopecia Universalis by Tofacitinib: A Case Report. Ann Intern Med. 2016;165:750–751. doi: 10.7326/L16-0125

Download citation file:

© 2019

×
Permissions

Published: Ann Intern Med. 2016;165(10):750-751.

DOI: 10.7326/L16-0125

©
2016 American College of Physicians
6 Citations

Related Articles
Update in Rheumatology: Evidence Published in 2014
Annals of Internal Medicine; 162 (9): W122-W126
Tofacitinib for the Treatment of Rheumatoid Arthritis
Annals of Internal Medicine; 159 (4): I-26
Tofacitinib in Combination With Nonbiologic Disease-Modifying Antirheumatic Drugs in Patients With Active Rheumatoid Arthritis: A Randomized Trial
Annals of Internal Medicine; 159 (4): 253-261
Update in Rheumatology: Evidence Published in 2011
Annals of Internal Medicine; 157 (2): 114-119
View MoreView Less

Related Topics
Endocrine and Metabolism
Gastroenterology/Hepatology
Inflammatory Bowel Disease
Rheumatoid Arthritis
Rheumatology

Endocrine and Metabolism, Gastroenterology/Hepatology, Inflammatory Bowel Disease, Rheumatoid Arthritis, Rheumatology.

PubMed Articles
[JAK Inhibitors in Rheumatology].
Dtsch Med Wochenschr 2019;144(11):748-752.
Alopecia Universalis and Atopic Dermatitis Improvement with Dupilumab: Demonstration of a Shared Pathophysiology and Clinical Efficacy.
Skinmed ;17(2):139-140.
View More

Results provided by: PubMed

CONTINUE WITH LIMITED ACCESS
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
acp link acp
silverchair link silverchair

Copyright © 2019 American College of Physicians. All Rights Reserved.

Print ISSN: 0003-4819 | Online ISSN: 1539-3704

Privacy Policy

|

Conditions of Use

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy. | Accept
×

You need a subscription to this content to use this feature.

×
PDF Downloads Require Access to the Full Article.
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×
Access to this Free Content Requires Users to be Registered and Logged In. Please Choose One of the Following Options
Annals of Internal Medicine
To receive access to the full text of freely available articles, alerts, and more. You will be directed to acponline.org to complete your registration.
×